Sign in to view content

Elamipretide, a Mitochondria-Targeted Drug for the Treatment of Vision Loss

Scott W. Cousins, MD

Video
Published 2019

Related

Precision Subretinal Delivery for Cell and Gene Therapy
Allen C Ho, MD FASRS
Updates from the Field
2019
Percentage of Patients Maintained on Quarterly Anti-VEGF Dosing for the Treatment of Neovascular Age-Related Macular Degeneration Across Key Clinical Trials
David A. Eichenbaum, MD, FASRS
Annual Meeting Talks
2018
Becoming a Clinical Trialist
Nancy M. Holekamp, MD, FASRS
Updates from the Field
2022

Category: AMD-Non-Neovascular

See more